Cause and duration of heart failure may impact on the response to sacubitril/valsartan in patients with heart failure and reduced ejection fraction

被引：0
|
作者：
Mandal, Amit K. J. [1 ]
Missouris, Constantinos G. [1 ,2 ]
机构：
[1] Frimley Hlth NHS Fdn Trust, Dept Cardiol, Wexham Pk Hosp, Slough, Berks, England
[2] Univ Cyprus, Dept Cardiol, Sch Med, Nicosia, Cyprus
来源：
JOURNAL OF CARDIOVASCULAR MEDICINE | 2021年 / 22卷 / 03期
关键词：
D O I：
10.2459/JCM.0000000000001111
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [41] Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan
    Lin, Po-Lin
    Lee, Ying-Hsiang
    Liu, Lawrence Yu-Min
    Tsai, Cheng-Ting
    Yang, Ten-Fang
    Chiou, Wei-Ru
    Hsieh, Mu-Yang
    Chang, Hung-Yu
    Huang, Chun-Che
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [42] Beneficial effects of sacubitril/valsartan in heart failure with reduced ejection fraction: pas a cause du BNP?
    Pereira, Naveen L.
    Desai, Viral K.
    Jaffe, Allan S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (05) : 609 - 612
  • [43] Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review
    Zhirov, Igor V.
    Safronova, Natalia V.
    Tereshchenko, Sergey N.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (09) : 802 - 809
  • [44] Sacubitril valsartan in aged patients with heart failure and reduced ejection fraction: a safe and beneficial therapy
    Romero Otero, J. M.
    Cortes Garcia, M.
    Rodriguez Lopez, C.
    Balaguer German, J.
    Esteban Chapel, J. A.
    Nieto Roca, L.
    Martinez Milla, J.
    Taibo Urquia, M.
    Pello Lazaro, A. M.
    Tunon Fernandez, J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2538 - 2538
  • [45] Commentary to Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Buonacera, Agata
    Stancanelli, Benedetta
    Malatino, Lorenzo
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (04) : 331 - 332
  • [46] BENEFIT OF SACUBITRIL/VALSARTAN THERAPY IN CLINICALLY STABLE PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION
    Solomon, Scott D.
    McMurray, John
    Desai, Akshay
    Zile, Michael
    Swedberg, Karl
    Shi, Victor
    Lefkowitz, Martin
    Rocha, Ricardo
    Packer, Milton
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1349 - 1349
  • [47] Early Effects of Sacubitril/Valsartan on Exercise Tolerance in Patients with Heart Failure with Reduced Ejection Fraction
    Vitale, Giuseppe
    Romano, Giuseppe
    Di Franco, Antonino
    Caccamo, Giuseppa
    Nugara, Cinzia
    Ajello, Laura
    Storniolo, Salvo
    Sarullo, Silvia
    Agnese, Valentina
    Giallauria, Francesco
    Novo, Giuseppina
    Clemenza, Francesco
    Sarullo, Filippo M.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [48] Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction
    Sandhu, Alexander T.
    Ollendorf, Daniel A.
    Chapman, Richard H.
    Pearson, Steven D.
    Heidenreich, Paul A.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (10) : 681 - +
  • [49] Changes in glycated hemoglobin in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
    Stassinos, V.
    Bezati, S.
    Leftheriotis, D.
    Kardamis, C.
    Dourvas, P.
    Katsaras, D.
    Loisiou, M.
    Draganigos, A.
    Klonou, E.
    Flevari, P.
    EUROPEAN HEART JOURNAL, 2019, 40 : 379 - 379
  • [50] Efficacy and Dosage Pattern of Sacubitril/Valsartan in Chinese Heart Failure with Reduced Ejection Fraction Patients
    Iokfai Cheang
    Shi Shi
    Xinyi Lu
    Shengen Liao
    Xu Zhu
    Xi Su
    Qi Lu
    Jing Yuan
    Dachun Xu
    Min Zhang
    Cuilian Dai
    Jingfeng Wang
    Fang Yuan
    Yan Zhao
    Jingmin Zhou
    Xinli Li
    Journal of Cardiovascular Translational Research, 2022, 15 : 1192 - 1202
12345